3 studies found for:    20888992 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Alisertib;   Drug: Abiraterone acetate;   Drug: Prednisone
2 Unknown  Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Experimental: Cabazitaxel 15mg/m2;   Drug: Experimental: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2
3 Completed
Has Results
XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer
Conditions: Neoplasms;   Prostatic Neoplasms
Interventions: Drug: cabazitaxel (XRP6258) (RPR116258);   Drug: mitoxantrone;   Drug: prednisone

Indicates status has not been verified in more than two years